Abstract
Early studies revealed that a pituitary factor, growth hormone (GH), was in-volved in long bone growth and nitrogen retention and, without conclusive evidence, accepted theories suggested that GH interacted directly with target tissues to induce such adaptations in metabolism. The elegant studies by Salmon and Daughaday (1957) described a factor in normal serum that, when added to cartilage expiants, stimulated the incorporation of 35S04 into proteoglycans. Serum from hypophysectomized rats failed to stimulate sulfate incorporation; however, when such rats were treated with GH, serum stimulation of sulfate uptake was observed within 24 hr. In contrast, direct addition of GH to the expiant media, either in the -presence or absence of hypophysectomized rat serum, failed to stimulate sulfate incorporation. Based on the bioassay response, the serum component was named sulfation factor.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams, S. O., S. P. Nissley, S. Handwerger and M. M. Rechler. 1983. Developmental patterns of insulin-like growth factor-I and -II syntheses and regulation in rat fibroblasts. Nature 302:150.
Bala, R. M., C. Wright, A. Bardai and G. R. Smith. 1978. Somatomedin bioactivity in serum and amniotic fluid during pregnancy. J. Clin. Endocrinol. Metab. 46:649.
Baxter, R. D., S. Axiak and R. L. Raison. 1982. Monoclonal antibody against somatomedin-C/ insulin-like growth factor-1. J. Clin. Endocrinol. Metab. 54:474.
Binoux, M. S., S. Hardouin, C. Lassarre and P. Hossenlopp. 1982. Evidence for production by the liver of two IGF binding proteins with similar molecular weights but different affinities for IGF-I and IGF-II. Their relations with serum and cerebrospinal fluid IGF binding proteins. J. Clin. Endocrinol. Metab. 55:600.
Breier, B. H., J. J. Bass, J. H. Butler and P. D. Gluckman. 1986. The somatotrophic axis in young steers: influence of nutritional status on pulsatile release of growth hormone and circulating concentrations of insulin-like growth factor 1. Journal of Endocrinology 111:209.
Butler, J. H. and P. D. Gluckman. 1986. Circulating insulin-like growth factor-binding proteins in fetal, neonatal and adult sheep. J. Endocrinol. 109:333.
Campbell, R. G., M. R. Taverner and D. M. Curie. 1985. Effects of sex and energy intake between 48 and 90 kg live weight on protein deposition in growing pigs. Anim. Prod. 40:497.
Chung, C. S., T. D. Etherton and J. P. Wiggins. 1985. Stimulation of swine growth by porcine growth hormone. J. Anim. Sci. 60:118.
Clemmons, D. R., L. E. Underwood, P. G. Chatelain and J. J. Van Wyk. 1983. Liberation of immunoreactive somatomedin-C from its binding proteins by proteolytic enzymes and heparin. J. Clin. Endocrinol. Metab. 56:384.
Clemmons, D. R., L. E. Underwood, E. C. Ridgeway, B. Kliman and J. J. Van Wyk. 1981. Hyperprolactinemia is associated with increased immunoreactive somatomedin C in hypopituitarism. J. Clin. Endocrinol. Metab. 52:731.
Copeland, K. C., L. E. Underwood and J. J. Van Wyk. 1980. Induction of immunoreactive somatomedin-C in human serum by growth hormone: dose response relationships and effect on chromatographic profiles. J. Clin. Endocrinol. Metab. 50:690.
Daughaday, W. 1977. Hormonal regulation of growth by somatomedin and other growth factors. Clinics in Endocrinology and Metabolism. 6:117.
Daughaday, W. 1983. The somatomedin hypothesis: origins and recent developments in insulinlike growth factors. In: E. M. Spencer (Ed.) Insulin-Like Growth Factors/Somatomedins. pp 3–11. Walter de Gruyter, Berlin.
Daughaday, W. H., I. K. Mariz and S. L. Blethen. 1980. Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum. J. Clin. Endocrinol. Metab. 51:781.
Daughaday, W. H., K. A. Parker, S. Borowsky, B. Trivedia and M. Kapedia. 1982. Measurement of somatomedin related peptides in fetal, neonatal and maternal rat serum by insulin-like growth factor (IGF) I radioimmunoassay, IGF-II radioreceptor assay (RRA) and multiplication-stimulating activity RRA after acid-ethanol extraction. Endocrinology 110:575.
D’Ercole, A. J., G. T. Applewhite and L. E. Underwood. 1980. Evidence that somatomedin is synthesized by multiple tissues in the fetus. Dev. Biol. 75:315.
Dulak, N. and H. M. Temin. 1973. A partially purified polypeptide fraction from rat liver cell conditioned medium with multiplication stimulating activity for embryo fibroblasts. J. Cell. Physiol. 81:153.
Eigenmann, J. E., D. F. Patterson and E. R. Froesch. 1984. Body size parallels insulin-like growth factor I levels but not growth hormone secretory capacity. Acta Endocrinol. 106:448.
Elsasser, T. H., A. C. Hammond, T. S. Rumsey and R. Fayer. 1985. Changes in plasma growth hormone, somatostatin-like immunoreactivity and somatomedin-C concentrations in steers during infection with Sarcocystis cruzi. Abstr. Proc. Endocrinol. Soc. p 29.
Elsasser, T. H., T. S. Rumsey and A. C. Hammond. 1986. Dietary regulation of somatomedin-C in beef cattle. J. Nutr. 116:XXXVI.
Elsasser, T. H., M. Pello and T. S. Rumsey. 1987. Somatomedin-C (SMC) and binding protein responses to growth hormone in cattle. J. Anim. Sci. 65 (Suppl. 1):256.
Etherton, D. and P. E. Walton. 1986. Hormonal and metabolic regulation of lipid metabolism in domestic livestock. J. Anim. Sci. 63 (Suppl. 2):76.
Froesch, E. R., H. Burgi, E. B. Ramseier, P. Bally and A. Labhart. 1963. Antibody-suppressible and nonsuppressible insulin-like activities in human serum and their physiological significance. An insulin assay with adipose tissue of increased precision and specificity. J. Clin. Invest. 42:1816.
Froesch, E. R., C. Schmid, I. Zangger, E. Schoenle, E. Eigenmann and J. Zapf. 1986. Effects of IGF/somatomedins on growth and differentiation of muscle and bone. J. Anim. Sci. 63 (Suppl. 2):57.
Furlanetto, R. W. 1980. The somatomedin-C binding protein: Evidence for a heterologous subunit structure. Endocrinology 51:12.
Furlanetto, R. W., L. E. Underwood, J. J. Van Wyk and A. J. D’Ercole. 1977. Estimation of somatomedin-C levels in normals and patients with pituitary disease. J. Clin. Invest. 60:648.
Gahagan, J. H., R. J. Martin and R. M. Leach. 1980. Serum somatomedin activity in two animal models as measured using chick epiphyseal plate cartilage bioassay. Proc. Soc. Exp. Biol. Med. 163:455.
Gluckman, P. D., K. Uthne, D. M. Styne, S. L. Kaplan, A. M. Rudolph and M. M. Grumbach. 1979. Hormone ontogeny in the ovine fetus. IV. Serum somatomedin activity in the fetal and neonatal lamb and pregnant ewe: correlation with maternal and fetal growth hormone, prolactin, and chorionic somatomammotropin. Pediatr. Res. 14:194.
Graham, D. E., M. M. Rechler, A. L. Brown, R. Frunzio, J. A. Romanus, C. B. Bruni, H. J. Whitfield, S. P. Nissley, S. Seelig and S. Berry. 1986. Coordinate developmental regulation of high and low molecular weight mRNA’s for rat insulin-like growth factor II. Proc. Natl. Acad. Sei. USA 83:4519.
Hall, K., J. Brandt, G. Enberg and L. Fryklund. 1979. Immunoreactive somatomedin A in human serum. J. Clin. Endocrinol. Metab. 48:271.
Hall, K. and V. R. Sara. 1983. Growth and somatomedins. Vitam. Horm. (N.Y.) 40:175.
Hammond, J. M., J. L. F. Baranao, D. A. Skaleris, M. M. Rechler and A. P. Knight. 1984. Somatomedin (Sm) production by cultured porcine granulosa cells (GC). J. Steroid Biochem. 20:1597.
Hintz, R. L. and F. Liu. 1977. Demonstration of specific plasma protein binding sites for somatomedin. J. Clin. Endocrinol. Metab. 45:988.
Hintz, R. L., F. Liu, D. Chang and E. R. Rinderknecht. 1983. The use of synthetic peptides for the development of radioimmunoassays for insulin-like growth factors. In: E. M. Spencer (Ed.) Insulin-Like Growth Factors/Somatomedins. pp 169–176. Walter de Gruyter, Berlin.
Honegger, A. and R. E. Humbel. 1986. Insulin-like growth factors I and II in fetal and adult bovine serum. J. Biol. Chem 261:569.
Hurley, T. W., A. J. D’Ercole, S. Handwerger, L. E. Underwood, R. W. Furlanetto and R. E. Fellows. 1977. Ovine placental lactogen induces somatomedin: a possible role in fetal growth. Endocrinology 101:1635.
Isley, W. L., L. E. Underwood and D. R. Clemmons. 1984. Changes in plasma somatomedin-C in response to ingestion of diets with variable protein and energy content. J. Parent. Ent. Nutr. 8:407.
Kato, Y., Y. Nomura, M. Tsuji, M. Konoshita, H. Ohmae and F. Suzuki. 1981. Somatomedin-like peptide(s) isolated from fetal bovine cartilage (cartilage-derived factor): isolation and some properties. Proc. Natl. Acad. Sci. USA 78:6831.
Lund-Larsen, T. R. and H. Bakke. 1975. Growth hormone and somatomedin activities in lines of pigs selected for rate of gain and thickness of backfat. Acta Agr. Scand. 25:231.
Lund-Larsen, T. R., A. Sundby, V. Kruse and W. Velle. 1977. Relations between growth rate, serum somatomedin and plasma testosterone in young bulls. J. Anim. Sci. 44:189.
Maes, M., L. E. Underwood, G. Gerard and J. M. Ketelslegers. 1984. Relationship between plasma somatomedin-C and liver somatogenic binding sites in neonatal rats during malnutrition and after short and long term refeeding. Endocrinology 115:786.
McCusker, R. H., D. R. Campion and D. R. Clemmons. 1986. The ontogeny and regulation of insulin-like growth factor-somatomedin (IGF-1) binding proteins in fetal and maternal porcine plasma and serum. J. Anim. Sci. 63 (Suppl. 1):242.
Marshall, R. N., L. E. Underwood, S. J. Viona, D. B. Foushee and J. J. Van Wyk. 1974. Characterization of the insulin and somatomedin-C receptors in human placental cell membranes. J. Clin. Endocrinol. Metab. 39:283.
Merimee, T. J., J. Zapf and E. R. Froesch. 1981. Dwarfism in the pygmy: an isolated deficiency of insulin-like growth factor I. N. Engl. J. Med. 305:965.
Phillips, L. S., D. S. Belosky, L. A. Reichard, H. S. Young, S. R. Berkowitz and M. F. Pertcheck. 1979. Somatomedin(s) and somatomedin inhibitor(s) in normal and diabetic serum. In: G. Giordano. J. J. Van Wyk and F. Minuto (Ed.) Somatomedins and Growth, pp 209–212. Academic Press, New York.
Pierson, R.W. and H. M. Temin. 1972. The partial purification from calf serum of a fraction with multiplication-stimulating activity for chicken fibroblasts in culture and with non-suppressible insulin-like activity. J. Cell. Physiol. 79:319.
Prewitt, T. E., A. J. D’Ercole, B. R. Switzer and J. J. Van Wyk. 1982. Relationship of serum immunoreactive somatomedin-C to dietary protein and energy in growing rats. J. Nutr. 112:144.
Rabinovitch, A., C. Quigley, T. Russell, Y. Patel and D. H. Mintz. 1982. Insulin and multiplication stimulating activity (an insulin-like growth factor) stimulate islet beta cell replication in neonatal rat pancreatic monolayer cultures. Diabetes 31:160.
Rechler, M. M., H. J. Eisen, O. Z. Higa, S. P. Nissley, A. C. Moses, E. E. Schilling, I. Fennoy, C. B. Bruni, L. S. Phillips and K. L. Baird. 1979. Characterization of a Somatomedin (Insulin-like Growth Factor) Synthesized by Fetal Rat Liver Organ Cultures. J. Biol. Chem. 254:7942.
Rechler, M. M., J. Zapf, S. P. Nissley, E. R. Froesch, A. C. Moses, J. M. Podskalny, E. E. Schilling and R. E. Humbel. 1980. Interactions of insulin-like growth factors I and II and multiplication-stimulating activity with receptors and serum carrier proteins. Endocrinology 107:1451.
Rinderknecht, E. and R. E. Humbel. 1978. Primary structure of human insulin-like growth factor II. FEBS Lett. 89:283.
Ritzen, E. M., B. Froysa, B. Gustafsson, G. Westerholm and E. Diczfalusy. 1982. Improved in vitro Bioassay of Follitropin. Horm. Rest. 16:42.
Rotwein, P., K. M. Pollock, D. K. Didier and G. G. Krivi. 1986. Organization and sequence of the human insulin-like growth factor I gene. J. Biol. Chem. 261:4828.
Salmon, W. D., Jr. and W. H. Daughaday. 1957. A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vivo. J. Lab. Clin. Med. 49:825.
Sara, V. R., K. Hall, P. Lins and L. Fryklund. 1980. Serum levels of immunoreactive somatomedin A in the rat: some developmental aspects. Endocrinology 107:622.
Scamurra, R. S., N. C. Steele, T. J. Caperna and M. L. Failla. 1986. Comparison of swine serum pretreatment methods for quantifying insulin-like growth factor I (IGF-I). J. Anim. Sci. 63 (Suppl. 1):224.
Schalch, D. S., U. E. Heinrich, J. G. Koch, C. J. Johnson and R. J. Schlueter. 1978. Nonsup-pressible insulin-like activity (NSILA). I. Development of a new sensitive competitive protein-binding assay for determination of serum levels. J. Clin. Endocrinol. Metab. 46:664.
Schalch, D., D. Reismann, C. Emler, R. Humbel, C. H. Li, M. Peters and E. Lau. 1984. Insulinlike growth factor 1/somatomedin-C (IGF-1/SMC): comparison of natural, solid phase synthetic and recombinant DNA analog peptides in two radioligand assays. Endocrinology 115:2490.
Schoenle, E., J. Zapf, R. E. Humbel and E. R. Froesch. 1982. Insulin-like growth factor stimulates growth in hypophysectomized rats. Nature 296:252.
Schwander. J. C., C. Hauri, J. Zapf and E. R. Froesch. 1983. Synthesis and secretion of insulinlike growth factor and its binding protein by the perfused rat liver: dependence on growth hormone status. Endocrinology 113:297.
Scott, C. D., J. L. Martin and R. C. Baxter. 1985. Production of insulin-like growth factor I and its binding protein by adult rat hepatocytes in primary culture. Endocrinology 116:1094.
Spencer, E. M. 1979. Synthesis by cultured hepatocytes of somatomedin and its binding protein. FEBS Lett. 99:157.
Spencer, E. M., M. Ross and B. Smith. 1983. The identity of human insulin-like growth factors I and II with somatomedins C and A and homology with IGF I and II. In: E. M. Spencer (Ed.) Insulin-Like Growth Factors/Somatomedins. pp 81–96. Walter de Gruyter, Berlin.
Svoboda, M. E. and J. J. Van Wyk. 1984. Somatomedins. In: W. S. Hancock (Ed.) CRC Handbook of HPLC for the Separation of Amino Acids, Peptides and Proteins, pp 439–444. CRC Press, Boca Raton, FL.
Underwood, L. E., A. J. D’Ercole, K. C. Copeland, J. J. Van Wyk, T. Hurley and S. Handwerger. 1982. Development of a heterologous radioimmunoassay for somatomedin-C in sheep blood. J. Endocrinol. 93:31.
Underwood, L. E., R. L. Hintz, S. J. Voina and J. J. Van Wyk. 1972. Human somatomedin, the growth hormone dependent sulfation factor, is antilipolytic. J. Clin. Endocrinol. Metab. 35:194.
Vassilopoulou-Sellin, R. and L. S. Phillips. 1982. Extraction of somatomedin activity from rat liver. Endocrinology 110:582.
Wilkins, J. R. and A. J. D’Ercole. 1985. Affinity labeled plasma somatomedin-C/insulin-like growth factor I binding proteins. J. Clin. Invest. 75:1350.
Yang, Y. W. -H., M. M. Rechler, S. P. Nissley and J. E. Coligan. 1985b. Biosynthesis of rat insulin-like growth factor II. J. Biol. Chem. 260:2578.
Yang, Y. W. -H., J. A. Romanus, T. -Y. Liu, S. P. Nissley and M. M. Rechler. 1985a. Biosynthesis of rat insulin-like growth factor II. J. Biol. Chem. 260:2570.
Zapf, J. 1983. Determination of insulin-like growth factors: a survey of methods. In: E. M. Spencer (Ed.) Insulin-Like Growth Factors/Somatomedins. pp 155–168. Walter de Gruyter, Berlin.
Zapf, J., G. Jagars and E. R. Froesch. 1978. Evidence for the existence in human serum of large molecular weight nonsuppressible insulin-like activity (NSILA) different from small molecular weight forms. FEBS Lett. 90:135.
Zapf, J., M. Waldvogel and E. R. Froesch. 1975. Binding of nonsuppressible insulin-like activity to human serum: evidence for a carrier protein. Arch. Biochem. Biophys. 168:638.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
Steele, N.C., Elsasser, T.H. (1989). Regulation of Somatomedin Production, Release, and Mechanism of Action. In: Campion, D.R., Hausman, G.J., Martin, R.J. (eds) Animal Growth Regulation. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8872-2_13
Download citation
DOI: https://doi.org/10.1007/978-1-4684-8872-2_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-8874-6
Online ISBN: 978-1-4684-8872-2
eBook Packages: Springer Book Archive